Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

Leica SR GSD 3D Super-Resolution Microscope Voted Among Top 10 Innovations 2013

Published: Monday, December 09, 2013
Last Updated: Sunday, December 08, 2013
Bookmark and Share
The Scientist magazine chooses super-resolution microscope from Leica Microsystems as one of the year's best innovations for the second time.

The Leica SR GSD 3D super-resolution microscope has been voted third among the Top 10 Innovations 2013 by the prestigious magazine The Scientist.

The panel of judges, consisting of representatives from science, business, and the non-profit sector, selected the super-resolution system for 3D localization microscopy from more than 80 entries as one of the most innovative products with the potential to revolutionize life sciences.

The Leica SR GSD 3D enables scientists to visualize and study cellular structures and processes down to the molecular level. It is based on the GSDIM method (Ground State Depletion Microscopy followed by Individual Molecule Return), also known as dSTORM (direct Stochastic Optical Reconstruction Microscopy).

Scientists can now study sub-cellular structures and protein-protein interactions, for example the nuclear pore complex, in both 2D and 3D - at highest resolution achievable to date in commercial widefield fluorescence microscopy.

The Leica SR GSD 3D can achieve a resolution of 20 nanometers in the xy plane and 50 nanometers in the z axis. This capability provides new insights into biological systems and their functions, aiding in our understanding of disease processes and contributing to the development of new therapies.

At market launch in September 2013, the Leica SR GSD 3D scored excellent marks with scientists who tested the system and compared it to other imaging instruments. They certified the systems' outstanding precision in localizing single molecules, its system stability, optical performance, and ease of use. These qualities are essential for researchers to obtain reproducible results in the shortest time possible.

"This award highlights the impressive quality and performance of our high-resolution system and its importance for biomedical research - and it is a great reward for the whole team," comments Sebastian Tille, Director of Widefield Imaging, Life Science Division at Leica Microsystems. "We are all the more delighted with this award as the predecessor system had already won several awards for its innovation."

Launched in 2011, the predecessor Leica SR GSD was voted a Top 10 Innovation that year by The Scientist as well as the 2012 R&D100 Award and selected one of three 2012 R&D100 Editor's Choice Awards from R&D magazine. It was also awarded a 2012 Innovations Award by Microscopy Today, the magazine of the Microscopy Society of America.

With many years of experience developing STED (STimulated Emission Depletion) super-resolution technologies based on single point scanning confocal microscopy, Leica Microsystems has again raised the bar in nanoscopy with the Leica SR GSD 3D.

The company continues its series of innovations with the new Leica TCS SP8 STED 3X, a confocal platform for 3D super-resolution that was recently presented - together with the Leica SR GSD 3D - at the Annual Meeting of the Society for Neuroscience in San Diego, CA, USA.

Both will be shown as well from December 14 to 18 at the Annual Meeting of the American Society for Cell Biology in New Orleans, LA, USA.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Yale University and Leica Microsystems Partner
Yale welcomes scientists to participate in core facility opening and super-resolution workshops October 20 through 31, 2014.
Tuesday, September 30, 2014
Leica Microsystems and Leica Biosystems Strengthen Market Position in Brazil
Long-standing Leica distributors Aotec have been acquired.
Tuesday, April 23, 2013
Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos